Manufacturing Anti-Diabetics to Meet the Needs of the Growing Diabetes Market
With diabetes and the global anti-diabetes drug market on the rise, demand for GEA technologies for the production of these life-saving drugs is already high and set to increase, particularly in new markets and emerging economies
It is estimated that approximately 6.4% of the adult population worldwide has diabetes, leading to a huge demand for oral anti-diabetes drugs. To be able to cater for this demand, high-volume or mass production of these medicines is a fundamental requirement. It enables companies to produce goods faster and reduce the overall per unit production cost, allowing them to make anti-diabetes medications available to less-developed countries.
GEA has been instrumental in designing, producing and delivering innovative, integrated solutions for every stage of the manufacturing process: from materials handling to tablet coating, automation and monitoring. We continue to support this high-volume batch-based production with ongoing improvements and innovative developments.
One example is our range of double-sided tablet presses to accommodate the fact that many oral anti-diabetes medicines are bilayer combination drugs, consisting of two separate layers for each API.
Another trend that we have observed is the move towards continuous manufacturing (CM). Providing increased yields, lower utility consumption and reduced waste, CM meets the industry’s demands for improved production economics and increased manufacturing flexibility.
Focusing on quality during the whole product lifecycle and decreasing any associated risks, GEA is helping its customers to develop, evaluate and optimize continuous processing techniques to enable them to bring new products to market faster and cheaper.
Productos y tecnologías
Mostrar 4 de 25
Contained Materials Handling Systems
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
Continuous Direct Compression Line
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
Continuous Granulation Lines
Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma® - continuous high-shear granulation and drying lines.
Continuous Processing Lines for Pharma
At GEA, we believe that continuous processing improves the quality of pharmaceutical end products: by focusing on quality during the whole product lifecycle, not just “tested in” quality; and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks.
Downloads
GEA Insights
El avance que revolucionó el secado por atomización
En 1976, los ingenieros de NIRO respondieron a un reto competitivo replanteándose las posibilidades del secado por atomización. Su idea se materializó en la torre multietapa MSD. Cincuenta años después, ese mismo principio fundamental contribuye a transformar los líquidos en los productos en polvo que se utilizan en productos nutricionales esenciales y en medicamentos importantes en todo el mundo. Perfeccionada a lo largo de décadas de experiencia en ingeniería, conocimiento de las necesidades de los clientes y desarrollo continuo, la torre de atomización MSD es una historia de innovación con un impacto duradero.
Más allá de la máquina: cómo potenciar el rendimiento de la planta
El hecho de que una máquina sea eficiente no significa que la fábrica lo sea. La mejora real suele comenzar por ir más allá de los equipos individuales y comprender cómo los procesos, los sistemas energéticos y las decisiones operativas se influyen mutuamente. Se trata de un enfoque holístico diseñado para descubrir oportunidades que, de otro modo, podrían pasarse por alto.
Cómo una válvula transforma la manera de elaborar alimentos y bebidas
En las plantas de alimentación y bebidas, las válvulas suelen accionarse mediante aire comprimido. GEA Hydract® Actuation Technology mueve las válvulas mediante agua, en un circuito cerrado controlado digitalmente. El resultado es una válvula que puede mantenerse en su sitio con exactitud y regularse con precisión. Esto se traduce en un menor consumo energético y un mayor control.
